Cerus Corporation
CERS
#7102
Rank
C$0.88 B
Marketcap
C$4.40
Share price
-0.95%
Change (1 day)
133.20%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2025 (TTM): -C$10.25 Million

According to Cerus Corporation's latest financial reports the company's current earnings are C$0.19 Billion. In 2024 the company made an earning of -C$16.76 Million, an increase over its 2023 earnings that were of -C$40.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$10.25 Million-38.88%
2024 -C$16.76 Million-58.95%
2023 -C$40.82 Million-20.74%
2022 -C$51.5 Million-25.7%
2021 -C$69.31 Million-11.99%
2020 -C$78.75 Million-14%
2019 -C$91.57 Million21.73%
2018 -C$75.23 Million-0.65%
2017 -C$75.72 Million-10.96%
2016 -C$85.04 Million4.24%
2015 -C$81.58 Million50.99%
2014 -C$54.04 Million-10.08%
2013 -C$60.09 Million184.13%
2012 -C$21.15 Million-7.91%
2011 -C$22.97 Million
2009 -C$32.44 Million-24.69%
2008 -C$43.07 Million-25.2%
2007 -C$57.58 Million330.54%
2006 -C$13.38 Million1.49%
2005 -C$13.18 Million-61.02%
2004 -C$33.81 Million
2002 -C$83.62 Million10.02%
2001 -C$76 Million34.25%
2000 -C$56.62 Million61.02%
1999 -C$35.16 Million-18.81%
1998 -C$43.31 Million93.08%
1997 -C$22.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$5.27 B-51,806.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$20.61 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.35 B-3,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$13.39 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA